Literature DB >> 26884877

Circulating miR-122-5p as a potential novel biomarker for diagnosis of acute myocardial infarction.

Xin-Liang Yao1, Xue-Li Lu1, Cheng-Yun Yan1, Qi-Lin Wan1, Guan-Chang Cheng1, Yan-Ming Li1.   

Abstract

BACKGROUND: MicroRNAs (miRNAs) play key roles in cardiac development, and the expression of miRNAs is altered in the diseased heart. The aim of this study was to explore the value of circulating microRNA-122-5p (miR-122-5p) as a potential biomarker for acute myocardial infarction (AMI).
METHODS: Plasma samples from 50 patients with AMI and 39 healthy adults (non-AMI controls) were collected. The abundance of circulating miR-122-5p was measured using quantitative real-time PCR (qRT-PCR). The cTnI concentrations of these samples were analyzed by ELISA.
RESULTS: Our findings revealed that circulating miR-122-5p expression were increased in AMI patients at 4 h, 8 h, 12 h, and 24 h by contrast to those non-AMI controls and displayed similar trends to that of cTnI concentrations in AMI patients. Further study showed that there is a high correlation between circulating miR-122-5p and cTnI concentrations. At last, the receiver operating characteristic (ROC) curve was performed and showed that circulating miR-122-5p had considerable diagnostic accuracy for AMI with an area under curve (AUC) of 0.855.
CONCLUSIONS: Our results implied that circulating miR-122-5p could be a potential biomarker for AMI.

Entities:  

Keywords:  Acute myocardial infarction; biomarker; diagnosis; miR-122-5p

Mesh:

Substances:

Year:  2015        PMID: 26884877      PMCID: PMC4730090     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  23 in total

1.  MicroRNA signatures in total peripheral blood as novel biomarkers for acute myocardial infarction.

Authors:  Benjamin Meder; Andreas Keller; Britta Vogel; Jan Haas; Farbod Sedaghat-Hamedani; Elham Kayvanpour; Steffen Just; Anne Borries; Jessica Rudloff; Petra Leidinger; Eckart Meese; Hugo A Katus; Wolfgang Rottbauer
Journal:  Basic Res Cardiol       Date:  2010-10-01       Impact factor: 17.165

Review 2.  Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease?

Authors:  Esther E Creemers; Anke J Tijsen; Yigal M Pinto
Journal:  Circ Res       Date:  2012-02-03       Impact factor: 17.367

3.  National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes.

Authors:  David A Morrow; Christopher P Cannon; Robert L Jesse; L Kristin Newby; Jan Ravkilde; Alan B Storrow; Alan H B Wu; Robert H Christenson; Fred S Apple; Gary Francis; Wilson Tang
Journal:  Clin Chem       Date:  2007-03-23       Impact factor: 8.327

4.  The association of the expression of miR-122-5p and its target ADAM10 with human breast cancer.

Authors:  Sercan Ergün; Mustafa Ulasli; Yusuf Ziya Igci; Mehri Igci; Sevil Kırkbes; Ersin Borazan; Ahmet Balik; Önder Yumrutaş; Celalettin Camci; Ecir Ali Cakmak; Ahmet Arslan; Serdar Oztuzcu
Journal:  Mol Biol Rep       Date:  2014-10-16       Impact factor: 2.316

5.  miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1.

Authors:  Jinhong Chang; Emmanuelle Nicolas; Debora Marks; Chris Sander; Anthony Lerro; Marie Annick Buendia; Chunxiao Xu; William S Mason; Thomas Moloshok; Roque Bort; Kenneth S Zaret; John M Taylor
Journal:  RNA Biol       Date:  2004-07-01       Impact factor: 4.652

6.  Circulating miR-210 predicts survival in critically ill patients with acute kidney injury.

Authors:  Johan M Lorenzen; Jan T Kielstein; Carsten Hafer; Shashi K Gupta; Philipp Kümpers; Robert Faulhaber-Walter; Hermann Haller; Danilo Fliser; Thomas Thum
Journal:  Clin J Am Soc Nephrol       Date:  2011-06-23       Impact factor: 8.237

7.  MicroRNAs: Processing, Maturation, Target Recognition and Regulatory Functions.

Authors:  Girish C Shukla; Jagjit Singh; Sailen Barik
Journal:  Mol Cell Pharmacol       Date:  2011

8.  Sensitive troponin I assay in early diagnosis of acute myocardial infarction.

Authors:  Till Keller; Tanja Zeller; Dirk Peetz; Stergios Tzikas; Alexander Roth; Ewa Czyz; Christoph Bickel; Stephan Baldus; Ascan Warnholtz; Meike Fröhlich; Christoph R Sinning; Medea S Eleftheriadis; Philipp S Wild; Renate B Schnabel; Edith Lubos; Nicole Jachmann; Sabine Genth-Zotz; Felix Post; Viviane Nicaud; Laurence Tiret; Karl J Lackner; Thomas F Münzel; Stefan Blankenberg
Journal:  N Engl J Med       Date:  2009-08-27       Impact factor: 91.245

9.  miR-122-5p as a plasma biomarker of liver injury in fish exposed to microcystin-LR.

Authors:  M Florczyk; P Brzuzan; J Krom; M Woźny; A Łakomiak
Journal:  J Fish Dis       Date:  2015-09-08       Impact factor: 2.767

10.  Predictive value of circulating miR-328 and miR-134 for acute myocardial infarction.

Authors:  Fucheng He; Pin Lv; Xue Zhao; Xi Wang; Xuehan Ma; Weiwei Meng; Xianchun Meng; Shuling Dong
Journal:  Mol Cell Biochem       Date:  2014-05-16       Impact factor: 3.396

View more
  12 in total

1.  Should we expect novel biomarkers of myocardial infarction?

Authors:  Marek Kiliszek; Agata Maciejak
Journal:  Ann Transl Med       Date:  2016-06

2.  MiR-122-5p inhibits cell migration and invasion in gastric cancer by down-regulating DUSP4.

Authors:  Xiaofeng Xu; Feng Gao; Jianjiang Wang; Lan Tao; Jinsong Ye; Li Ding; Wei Ji; Xing Chen
Journal:  Cancer Biol Ther       Date:  2018-03-06       Impact factor: 4.742

Review 3.  Non-coding RNAs as biomarkers for acute myocardial infarction.

Authors:  Chen Wang; Qing Jing
Journal:  Acta Pharmacol Sin       Date:  2018-04-26       Impact factor: 6.150

Review 4.  MicroRNAs in Acute ST Elevation Myocardial Infarction-A New Tool for Diagnosis and Prognosis: Therapeutic Implications.

Authors:  Alina Ioana Scărlătescu; Miruna Mihaela Micheu; Nicoleta-Monica Popa-Fotea; Maria Dorobanțu
Journal:  Int J Mol Sci       Date:  2021-04-30       Impact factor: 5.923

5.  Bioinformatic screening for key miRNAs and genes associated with myocardial infarction.

Authors:  Ke Wu; Qiang Zhao; Zhengmei Li; Nannan Li; Qiang Xiao; Xiuchang Li; Quanming Zhao
Journal:  FEBS Open Bio       Date:  2018-04-19       Impact factor: 2.693

Review 6.  Epigenetic Biomarkers in Cardiovascular Diseases.

Authors:  Carolina Soler-Botija; Carolina Gálvez-Montón; Antoni Bayés-Genís
Journal:  Front Genet       Date:  2019-10-09       Impact factor: 4.599

7.  MiR-144-3p Enhances Cardiac Fibrosis After Myocardial Infarction by Targeting PTEN.

Authors:  Xiaolong Yuan; Jinchun Pan; Lijuan Wen; Baoyong Gong; Jiaqi Li; Hongbin Gao; Weijiang Tan; Shi Liang; Hao Zhang; Xilong Wang
Journal:  Front Cell Dev Biol       Date:  2019-10-29

8.  Comparison of the Clinical Value of miRNAs and Conventional Biomarkers in AMI: A Systematic Review.

Authors:  Baofu Wang; Yang Li; Xuezeng Hao; Jingjing Yang; Xiaowan Han; Haiyan Li; Tong Li; Dayang Wang; Yu Teng; Liang Ma; Yao Li; Mingjing Zhao; Xian Wang
Journal:  Front Genet       Date:  2021-06-17       Impact factor: 4.599

9.  Elevated plasma miRNA-122, -140-3p, -720, -2861, and -3149 during early period of acute coronary syndrome are derived from peripheral blood mononuclear cells.

Authors:  Xiang-Dong Li; Yue-Jin Yang; Lai-Yuan Wang; Shu-Bin Qiao; Xiang-Feng Lu; Yong-Jian Wu; Bo Xu; Hong-Fan Li; Dong-Feng Gu
Journal:  PLoS One       Date:  2017-09-29       Impact factor: 3.240

10.  Metabolic Dysregulation of the Lysophospholipid/Autotaxin Axis in the Chromosome 9p21 Gene SNP rs10757274.

Authors:  Sven W Meckelmann; Jade I Hawksworth; Daniel White; Robert Andrews; Patricia Rodrigues; Anne O'Connor; Jorge Alvarez-Jarreta; Victoria J Tyrrell; Christine Hinz; You Zhou; Julie Williams; Maceler Aldrovandi; William J Watkins; Adam J Engler; Valentina Lo Sardo; David A Slatter; Stuart M Allen; Jay Acharya; Jacquie Mitchell; Jackie Cooper; Junken Aoki; Kuniyuki Kano; Steve E Humphries; Valerie B O'Donnell
Journal:  Circ Genom Precis Med       Date:  2020-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.